The authors collected resource utilization and cost of treatment data (in US dollars, excluding physicians' fees) from the cost accounting systems of two Canadian hospitals (n=215) and seven US ...

ATLANTA -- The SGLT2 inhibitor empagliflozin (Jardiance) did not exactly prevent deaths and heart failure (HF) events when initiated atop other standard therapies for acute myocardial infarction (MI), ...

For stabilized AMI without left ventricular systolic dysfunction or HF, discontinuing β-blockers after 1 year or longer is noninferior to continuing it.

Acute myocardial infarction (AMI) continues to be a leading cause of death worldwide, necessitating rapid and accurate diagnosis to mitigate severe cardiac damage. The electrocardiogram (ECG) remains ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. During the first year of the COVID-19 pandemic, ...

Frailty manifests differently by age among patients who’ve experienced acute MI, a population-based study shows. While it is consistently linked to worse outcomes, people younger than 55 feel the ...

Among young acute MI patients, hospitalizations within the following year are more likely to occur in women than men, an analysis of the VIRGO trial shows. Data have previously shown that not only do ...

ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other ...

NEW YORK (MedscapeWire) Apr 17 -- Although many studies at academic centers have demonstrated the benefit of percutaneous intervention (PCI) for acute myocardial infarction (MI), new research reported ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...

Please provide your email address to receive an email when new articles are posted on . A liberal vs. restrictive transfusion strategy yielded similar rates of death or MI at 30 days in patients with ...